News | September 20, 2007

Cianna to Continue Innovation in SAVI Breast Brachytherapy Begun by BioLucent

September 21, 2007 — Cianna Medical has been created as a new company to focus exclusively on its innovative SAVI breast brachytherapy technology.

Cianna is a spinoff of BioLucent Inc., with Cianna retaining the same team that developed the SAVI technology.

The creation of Cianna Medical comes with the completion of Hologic Inc.'s acquisition of BioLucent and its MammoPad breast cushion business. Virtually all of BioLucent's leadership team will remain at Cianna Medical.

SAVI offers women who have had lumpectomy surgery a more convenient, five-day course of treatment than is available with external radiation. The standard course of treatment for external radiation is six to seven weeks and can create a significant disruption in the lives of women and their families.

In addition to a shorter course of treatment, the multi-catheter, expandable SAVI applicator provides a precisely targeted, contoured dose of radiation that treats tissue surrounding the lumpectomy cavity from the inside out.

This approach is designed to make the benefits of partial breast irradiation available to a larger group of women. It also gives more treatment planning flexibility to the radiation oncologist and physicist, and gives physicians the ability to control and contour the radiation dose.

For more information: www.ciannamedical.com

Related Content

Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...